Timothy F. Gallagher

Author

Also Known As

T. F. GALLAGHER, T. F. Gallagher, T. GALLAGHER, T. Gallagher, Timothy F Gallagher, Timothy F. Gallagher, Timothy Gallagher

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

New Frontier GlaxoSmithKline (United Kingdom)GlaxoSmithKline (United States)

About

Timothy F. Gallagher is an author at New Frontier specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	3.8K
2	Natural Sciences	6	6	337
3	Engineering	1	1	17
4	Allergy	1	1	120
5	Applied Physics	1	1	17

Timothy F. Gallagher

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis John C. Lee, Jeffrey T. Laydon, Peter McDonnell, Nature InflammationCytokineSignal TransductionSignaling PathwayMolecular Pathway	1994	3.3K
Pyridinyl Imidazole Inhibitors of p38 Mitogen-activated Protein Kinase Bind in the ATP Site Peter R. Young, Megan M. McLaughlin, Sanjay Kumar, Journal of Biological Chemistry	1997	573
1-Substituted 4-Aryl-5-pyridinylimidazoles: A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory Potency Jeffrey C. Boehm, Juanita M. Smietana, Margaret E. Sorenson, Journal of Medicinal Chemistry Aa Rat ModelLipid PeroxidationImmunologyCell DeathPharmacotherapy	1996	120
Pyrimidinylimidazole inhibitors of CSBP/P38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes Jerry L. Adams, Jeffrey C. Boehm, Shouki Kassis, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineLiver PhysiologyPyrimidinylimidazole InhibitorsHepatotoxicity	1998	113
Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity Jerry L. Adams, Jeffrey C. Boehm, Timothy F. Gallagher, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesMechanism Of Action	2001	105
Nonpeptidic urotensin‐II receptor antagonists I: <i>in vitro</i> pharmacological characterization of SB‐706375 Stephen A. Douglas, David J. Behm, Nambi Aiyar, British Journal of Pharmacology Hu-ii BindingMolecular BiologyRat AortaPharmacotherapyExperimental Pharmacology	2005	53
Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases Timothy J. Miles, Jeffrey M. Axten, Christopher W. Barfoot, Bioorganic & Medicinal Chemistry Letters AntibioticsMedicineNovel Amino-piperidinesAntibacterial AgentAntimicrobial Chemotherapy	2011	46
Regioselective synthesis of .DELTA.6-, .DELTA.7-, and .DELTA.8-14.alpha.-cyanosterol derivatives: versatile precursors to 14.alpha.-demethylase inhibitors Timothy F. Gallagher, Jerry L. Adams The Journal of Organic Chemistry Altmetric Attention ScoreOrganic ChemistryChemistryChemical DerivativePharmaceutical Chemistry	1992	25
Synthesis of methyl 2-acetamido-2,3,6-trideoxy-β-l-lyxo-hexopyranoside Timothy F. Gallagher, Derek Horton Carbohydrate Research Bioorganic ChemistryNatural SciencesChemistryNatural Product SynthesisSynthetic Chemistry	1983	17
Enhancement of the autoionization rate of two-photon excited states of Ba (6d_{5/2}nd_{5/2(3/2)})_{J=4} near the Ba^{+} 6d_{3/2} limit R. Kachru, N. H. Tran, H Van Linden Van Den Heuvell, Physical review. A, General physics Quantum PhotonicsEngineeringLocalized Excited StateAutoionization RateTwo-photon Excitation	1984	17

Page 1